The invention describes a method of killing or inhibiting the growth of the malaria causing pathogen Plasmodium falciparum by exposing the pathogen to a preparation containing methylene-bis-aspidinol, desaspidin, and/or aspidin.
This application is a continuation of the application Ser. No. 08/682,297, filed on Jul. 17, 1996 now U.S. Pat. No. 5,684,035.
The present invention relates to therapeutic uses of naphthoquinones and/or aspidinol derivatives. More particularly, it relates to their use as antimalarial agents.
